• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Acamol Tsinun & Shapa’at Night
    / Teva


    Status in Israel
    OTC

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Caplets

    14

    not in the basket chart 89551 9675

    Caplets

    DAY & NIGHT: 35 + 14

    not in the basket chart 14238 9245

    Related information


    Dosage

    Adults and children above 12 years of age: 1-2 caplets at bedtime.
    Patients above the age of 60 years: consult the doctor before using this medicine, as they may be sensitive to preparations of this kind.
    Upon concomitant use of Acamol® Tsinun & Shapa’at Day, exchange a dose of
    Acamol® Tsinun & Shapa’at Day with a dose of Acamol® Tsinun & Shapa’at Night
    and do not take it as a supplement to the maximum dosage recommended above for Acamol® Tsinun & Shapa’at Night.
    See package insert (OTC).


    Indications

    For the relief of cold, cough and nasal congestion associated with fever and pain, for night care.


    Contra-Indications

    Known hypersensitivity to any ingredient of the preparation.
    Pregnancy. Lactation.
    Concomitant use with MAOIs or within 14 days of discontinuation of such therapy.
    Asthma.
    Severe heart disease or hypertension.
    Patients who have lung disease.
    Patients who sufferg from a chronic cough.
    Concomitant use with other paracetamol containing preparations.
    The following diseases or conditions: blood vessel disease, a severe disease of the liver or kidneys, overactive thyroid gland, high intraocular pressure (glaucoma), prostate problems, breathing difficulties or diabetes.
    Asthma or other lower respiratory tract conditions, narrow-angle glaucoma, stenosing peptic ulcer, symptomatic prostatic hypertrophy, bladder neck obstruction, pyloroduodenal obstruction. Concomitant use with MAOI therapy or within 14 days of discontinuation of such therapy. Severe hypertension and severe coronary artery disease. Subjects in, or at risk of developing respiratory failure (due to dextromethorphan content, in common with other centrally acting antitussive agents).


    Special Precautions

    If the patient developed skin side effects in the past as a result of taking preparations containing paracetamol, do not administer preparations containing paracetamol, so that severe skin effects will not recur.
    The preparation contains paracetamol, which may cause liver damage when:
    Given at a dosage higher than recommended or for a prolonged period.
    Alcoholic beverages are consumed during the course of treatment.
    Taking additional medicines, which affect liver function.
    See package insert (OTC).


    Side Effects

    Paracetamol can, in rare cases, cause the appearance of severe skin diseases, whose signs can be: redness, rash, blisters, widespread skin damage.
    See package insert (OTC).


    Pregnancy and Lactation

    If you are pregnant or breastfeeding, do not use this medicine.


    Manufacturer
    Teva Pharmaceutical Industries Ltd, Israel
    CLOSE